AI Mental Health Startup Kintsugi Shuts Down After FDA Delays Drain Funding, Open-Sources Depression Detection Technology

Kintsugi, a California startup that spent seven years developing AI software to detect depression and anxiety from speech patterns, is shutting down and open-sourcing its technology after FDA regulatory delays drained its funding before approval could be secured.

• California-based startup Kintsugi is shutting down and open-sourcing its AI technology after failing to secure FDA clearance in time, having spent seven years developing software that detects signs of depression and anxiety from speech patterns.
• The FDA's lengthy De Novo approval process, compounded by federal government shutdowns and a framework poorly suited for adaptive AI systems, drains the startup's funding before its final submission can be completed.
• While most of Kintsugi's mental health technology is being released publicly, its deepfake audio detection capability — a byproduct of training on synthetic speech — is being withheld due to its commercial potential and the fact that it falls outside FDA oversight.